Group ID|Group Name|Treatment Sequence|Treatment Age|Treatment Type|Treatment Quantity|Treatment Unit|Treatment Application|Treatment Remarks|No of individuals in study|Species|Strain|Sex|Age|Group Endpoints|Individual ID|Group ID|Age at death|Pathology type |Pathology location|Pathology Description|
1011-3-1|n/a,n/a|Sequence:1, Age:100,Type:none (controls),Quantity:0,Unit:grays,Application:External exposure, Remarks:n/a|747 (0 in ERA)|Mouse|Mouse, CBA/H|Male|Young Adult|Lifespan study with diagnosis of myeloid leukaemia from histopathology and haematology|No information on individuals available for this study
1011-3-2|n/a,n/a|Sequence:1, Age:100,Type:X-rays whole body,Quantity:1.06,Unit:grays,Application:External exposure, Remarks:10 d continuosly 23.5h/d starting 0.24 Gy/d reduce by 45% every 2 d|734 (0 in ERA)|Mouse|Mouse, CBA/H|Male|Young Adult|Lifespan study with diagnosis of myeloid leukaemia from histopathology and haematology|No information on individuals available for this study
1011-3-3|n/a,n/a|Sequence:1, Age:100,Type:X-rays whole body,Quantity:1.98,Unit:grays,Application:External exposure, Remarks:10 d continuosly 23.5h/d starting 0.48 Gy/d reduce by 45% every 2 d|739 (0 in ERA)|Mouse|Mouse, CBA/H|Male|Young Adult|Lifespan study with diagnosis of myeloid leukaemia from histopathology and haematology|No information on individuals available for this study
1011-3-4|n/a,n/a|Sequence:1, Age:100,Type:X-rays whole body,Quantity:2.6,Unit:grays,Application:External exposure, Remarks:10 d continuosly 23.5h/d starting 0.72 Gy/d reduce by 45% every 2 d|746 (0 in ERA)|Mouse|Mouse, CBA/H|Male|Young Adult|Lifespan study with diagnosis of myeloid leukaemia from histopathology and haematology|No information on individuals available for this study
1011-3-5|n/a,n/a|Sequence:1, Age:100,Type:neutrons <100 keV,Quantity:0.85,Unit:grays,Application:Injection, intraperitoneal, Remarks:90 mBq|732 (0 in ERA)|Mouse|Mouse, CBA/H|Male|Young Adult|Lifespan study with diagnosis of myeloid leukaemia from histopathology and haematology|No information on individuals available for this study
1011-3-6|n/a,n/a|Sequence:1, Age:100,Type:neutrons <100 keV,Quantity:1.86,Unit:grays,Application:Injection, intraperitoneal, Remarks:180 MBq|754 (0 in ERA)|Mouse|Mouse, CBA/H|Male|Young Adult|Lifespan study with diagnosis of myeloid leukaemia from histopathology and haematology|No information on individuals available for this study
1011-3-7|n/a,n/a|Sequence:1, Age:100,Type:neutrons <100 keV,Quantity:3.05,Unit:grays,Application:Injection, intraperitoneal, Remarks:270 MBq|754 (0 in ERA)|Mouse|Mouse, CBA/H|Male|Young Adult|Lifespan study with diagnosis of myeloid leukaemia from histopathology and haematology|No information on individuals available for this study
		
